![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SAMD4B |
Gene summary for SAMD4B |
![]() |
Gene information | Species | Human | Gene symbol | SAMD4B | Gene ID | 55095 |
Gene name | sterile alpha motif domain containing 4B | |
Gene Alias | SMGB | |
Cytomap | 19q13.2 | |
Gene Type | protein-coding | GO ID | GO:0000288 | UniProtAcc | M0QZ22 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55095 | SAMD4B | LZE4T | Human | Esophagus | ESCC | 1.29e-03 | -3.68e-02 | 0.0811 |
55095 | SAMD4B | LZE7T | Human | Esophagus | ESCC | 4.84e-06 | 2.77e-01 | 0.0667 |
55095 | SAMD4B | LZE8T | Human | Esophagus | ESCC | 2.96e-15 | 1.28e-01 | 0.067 |
55095 | SAMD4B | LZE22D1 | Human | Esophagus | HGIN | 1.05e-02 | -3.64e-02 | 0.0595 |
55095 | SAMD4B | LZE22T | Human | Esophagus | ESCC | 7.60e-05 | 2.67e-01 | 0.068 |
55095 | SAMD4B | LZE24T | Human | Esophagus | ESCC | 5.31e-18 | 3.02e-01 | 0.0596 |
55095 | SAMD4B | LZE21T | Human | Esophagus | ESCC | 8.29e-04 | 1.23e-01 | 0.0655 |
55095 | SAMD4B | P1T-E | Human | Esophagus | ESCC | 1.29e-03 | 6.27e-01 | 0.0875 |
55095 | SAMD4B | P2T-E | Human | Esophagus | ESCC | 1.92e-22 | 1.86e-01 | 0.1177 |
55095 | SAMD4B | P4T-E | Human | Esophagus | ESCC | 6.46e-09 | 1.64e-01 | 0.1323 |
55095 | SAMD4B | P5T-E | Human | Esophagus | ESCC | 1.69e-19 | 3.19e-02 | 0.1327 |
55095 | SAMD4B | P8T-E | Human | Esophagus | ESCC | 1.18e-33 | 5.75e-01 | 0.0889 |
55095 | SAMD4B | P9T-E | Human | Esophagus | ESCC | 7.04e-13 | 1.45e-01 | 0.1131 |
55095 | SAMD4B | P10T-E | Human | Esophagus | ESCC | 9.82e-23 | 3.26e-01 | 0.116 |
55095 | SAMD4B | P11T-E | Human | Esophagus | ESCC | 1.99e-13 | 4.75e-01 | 0.1426 |
55095 | SAMD4B | P12T-E | Human | Esophagus | ESCC | 6.43e-13 | 1.06e-01 | 0.1122 |
55095 | SAMD4B | P15T-E | Human | Esophagus | ESCC | 4.80e-11 | 2.26e-01 | 0.1149 |
55095 | SAMD4B | P16T-E | Human | Esophagus | ESCC | 7.15e-12 | 6.18e-02 | 0.1153 |
55095 | SAMD4B | P17T-E | Human | Esophagus | ESCC | 1.38e-04 | 2.97e-01 | 0.1278 |
55095 | SAMD4B | P19T-E | Human | Esophagus | ESCC | 1.66e-04 | 2.92e-01 | 0.1662 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000641727 | Esophagus | HGIN | regulation of translation | 139/2587 | 468/18723 | 1.46e-19 | 7.98e-17 | 139 |
GO:190331120 | Esophagus | HGIN | regulation of mRNA metabolic process | 91/2587 | 288/18723 | 5.06e-15 | 9.78e-13 | 91 |
GO:000989626 | Esophagus | HGIN | positive regulation of catabolic process | 126/2587 | 492/18723 | 1.46e-12 | 2.09e-10 | 126 |
GO:003133126 | Esophagus | HGIN | positive regulation of cellular catabolic process | 112/2587 | 427/18723 | 5.15e-12 | 6.72e-10 | 112 |
GO:000640120 | Esophagus | HGIN | RNA catabolic process | 77/2587 | 278/18723 | 7.63e-10 | 6.36e-08 | 77 |
GO:000640220 | Esophagus | HGIN | mRNA catabolic process | 67/2587 | 232/18723 | 1.47e-09 | 1.13e-07 | 67 |
GO:000095617 | Esophagus | HGIN | nuclear-transcribed mRNA catabolic process | 40/2587 | 112/18723 | 4.44e-09 | 3.03e-07 | 40 |
GO:003465519 | Esophagus | HGIN | nucleobase-containing compound catabolic process | 98/2587 | 407/18723 | 1.44e-08 | 8.94e-07 | 98 |
GO:004670017 | Esophagus | HGIN | heterocycle catabolic process | 103/2587 | 445/18723 | 5.44e-08 | 2.99e-06 | 103 |
GO:004427018 | Esophagus | HGIN | cellular nitrogen compound catabolic process | 103/2587 | 451/18723 | 1.10e-07 | 5.56e-06 | 103 |
GO:001943917 | Esophagus | HGIN | aromatic compound catabolic process | 105/2587 | 467/18723 | 1.89e-07 | 9.31e-06 | 105 |
GO:190331310 | Esophagus | HGIN | positive regulation of mRNA metabolic process | 38/2587 | 118/18723 | 2.46e-07 | 1.16e-05 | 38 |
GO:190136117 | Esophagus | HGIN | organic cyclic compound catabolic process | 106/2587 | 495/18723 | 1.94e-06 | 7.13e-05 | 106 |
GO:00342496 | Esophagus | HGIN | negative regulation of cellular amide metabolic process | 66/2587 | 273/18723 | 2.74e-06 | 9.60e-05 | 66 |
GO:00171486 | Esophagus | HGIN | negative regulation of translation | 59/2587 | 245/18723 | 1.03e-05 | 2.96e-04 | 59 |
GO:006101318 | Esophagus | HGIN | regulation of mRNA catabolic process | 43/2587 | 166/18723 | 2.48e-05 | 6.53e-04 | 43 |
GO:000028810 | Esophagus | HGIN | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 19/2587 | 56/18723 | 1.10e-04 | 2.33e-03 | 19 |
GO:006101410 | Esophagus | HGIN | positive regulation of mRNA catabolic process | 24/2587 | 87/18723 | 5.46e-04 | 7.73e-03 | 24 |
GO:004348818 | Esophagus | HGIN | regulation of mRNA stability | 37/2587 | 158/18723 | 7.53e-04 | 9.97e-03 | 37 |
GO:004348718 | Esophagus | HGIN | regulation of RNA stability | 39/2587 | 170/18723 | 8.42e-04 | 1.09e-02 | 39 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SAMD4B | SNV | Missense_Mutation | novel | c.893N>T | p.Gly298Val | p.G298V | Q5PRF9 | protein_coding | deleterious(0.02) | probably_damaging(0.999) | TCGA-66-2769-01 | Lung | lung squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
SAMD4B | SNV | Missense_Mutation | novel | c.1186N>A | p.Val396Ile | p.V396I | Q5PRF9 | protein_coding | tolerated(0.39) | benign(0) | TCGA-85-A4QR-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
SAMD4B | SNV | Missense_Mutation | rs781488581 | c.575N>G | p.Asp192Gly | p.D192G | Q5PRF9 | protein_coding | tolerated(0.12) | benign(0.017) | TCGA-85-A50Z-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | etoposide | PD |
SAMD4B | SNV | Missense_Mutation | novel | c.365N>A | p.Ser122Asn | p.S122N | Q5PRF9 | protein_coding | deleterious(0) | possibly_damaging(0.462) | TCGA-BA-6871-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
SAMD4B | SNV | Missense_Mutation | rs571162695 | c.1070N>A | p.Arg357His | p.R357H | Q5PRF9 | protein_coding | deleterious(0.04) | benign(0.323) | TCGA-CR-7394-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
SAMD4B | SNV | Missense_Mutation | novel | c.1594N>T | p.Arg532Trp | p.R532W | Q5PRF9 | protein_coding | deleterious(0.03) | probably_damaging(0.985) | TCGA-P3-A6SW-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unspecific | Cisplatin | Complete Response |
SAMD4B | SNV | Missense_Mutation | novel | c.1547N>G | p.Gln516Arg | p.Q516R | Q5PRF9 | protein_coding | deleterious(0) | benign(0.081) | TCGA-QK-A6VB-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
SAMD4B | SNV | Missense_Mutation | c.1544C>T | p.Thr515Met | p.T515M | Q5PRF9 | protein_coding | deleterious(0.01) | possibly_damaging(0.609) | TCGA-BR-4362-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SAMD4B | SNV | Missense_Mutation | c.329N>T | p.Ala110Val | p.A110V | Q5PRF9 | protein_coding | deleterious(0.04) | benign(0.001) | TCGA-BR-8363-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SAMD4B | SNV | Missense_Mutation | c.650N>T | p.Gly217Val | p.G217V | Q5PRF9 | protein_coding | tolerated(0.08) | benign(0.108) | TCGA-CD-A4MG-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |